Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy

Atypical antipsychotics are highly effective antischizophrenic medications but their clinical utility is limited by adverse metabolic sequelae. We investigated whether upregulation of macrophage migration inhibitory factor (MIF) underlies the insulin resistance that develops during treatment with th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Invest
Autori principali: Cui, Donghong, Peng, Yanmin, Zhang, Chengfang, Li, Zezhi, Su, Yousong, Qi, Yadan, Xing, Mengjuan, Li, Jia, Kim, Grace E., Su, Kevin N., Xu, Jinjie, Wang, Meiti, Ding, Wenhua, Piecychna, Marta, Leng, Lin, Hirasawa, Michiru, Jiang, Kaida, Young, Lawrence, Xu, Yifeng, Qi, Dake, Bucala, Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Clinical Investigation 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205380/
https://ncbi.nlm.nih.gov/pubmed/30295645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI93090
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi